PROTEOSTASIS THERAPEUTICS IN - COM (PTI)

CUSIP: 74373B109

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
18,457,359
Share change
-526,653
Total reported value
$86,598,000
Price per share
$4.68
Number of holders
49
Value change
-$4,226,710
Number of buys
22
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 74373B109?
CUSIP 74373B109 identifies PTI - PROTEOSTASIS THERAPEUTICS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTEOSTASIS THERAPEUTICS IN - COM (PTI) as of Q2 2017

As of 30 Jun 2017, PROTEOSTASIS THERAPEUTICS IN - COM (PTI) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,457,359 shares. The largest 10 holders included Cormorant Asset Management, LLC, NEA Management Company, LLC, FMR LLC, JENNISON ASSOCIATES LLC, Hillhouse Capital Management, Ltd., PRICE T ROWE ASSOCIATES INC /MD/, Marshall Wace North America L.P., FIL Ltd, Rock Springs Capital Management LP, and HarbourVest Partners LLC. This page lists 49 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.